These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7226972)

  • 1. Cefamandole bone diffusion in patients undergoing total hip replacement.
    Roncoroni AJ; Manuel C; Nedjar C; Bauchet J; Mariani D
    Chemotherapy; 1981; 27(3):166-72. PubMed ID: 7226972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalothin and cefamandole penetration into bone, synovial fluid, and wound drainage fluid.
    Schurman DJ; Hirshman HP; Burton DS
    J Bone Joint Surg Am; 1980 Sep; 62(6):981-5. PubMed ID: 7430187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of cefamandole, cefuroxime and cephradine during total hip replacement.
    Davies AJ; Lockley RM; Jones A; el-Safty M; Clothier JC
    J Antimicrob Chemother; 1986 May; 17(5):637-40. PubMed ID: 3722034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience in pharmacology in bone and joint surgery with cefamandole and cephalothin.
    Schurman DJ; Moser K; Hirshman HP; Burton DS
    Scand J Infect Dis Suppl; 1980; suppl 25():49-52. PubMed ID: 6937952
    [No Abstract]   [Full Text] [Related]  

  • 5. The penetration of ceftriaxone and cefamandole into bone, fat and haematoma and relevance of serum protein binding to their penetration into bone.
    Lovering AM; Walsh TR; Bannister GC; MacGowan AP
    J Antimicrob Chemother; 2001 Apr; 47(4):483-6. PubMed ID: 11266427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone concentrations of cefuroxime and cefamandole in the femoral head in 96 patients undergoing total hip replacement surgery.
    Leigh DA; Marriner J; Nisbet D; Powell HD; Church JC; Wise K
    J Antimicrob Chemother; 1982 Apr; 9(4):303-11. PubMed ID: 7085533
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone and serum concentrations of five cephalosporin drugs. Relevance to prophylaxis and treatment in orthopedic surgery.
    Williams DN; Gustilo RB; Beverly R; Kind AC
    Clin Orthop Relat Res; 1983 Oct; (179):253-65. PubMed ID: 6617025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefamandole in osseous tissue.
    Lunke RJ; Fitzgerald RH; Washington JA
    Antimicrob Agents Chemother; 1981 May; 19(5):851-8. PubMed ID: 7294769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of the diffusion of cefamandole into bronchial secretions (author's transl)].
    Bergogne-Berezin E; Berthelot G; Even P
    Nouv Presse Med; 1981 Jun; 10(25):2089-91. PubMed ID: 7267304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration characteristics of cefamandole into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery.
    Olson NH; Nightingale CH; Quintiliani R
    Ann Thorac Surg; 1980 Feb; 29(2):104-8. PubMed ID: 6965578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the diffusion rate of cefamandole in various human tissue (author's transl)].
    Plaue R; Müller O; Fabricius K; Bethke RO
    Arzneimittelforschung; 1978; 28(12):2343-9. PubMed ID: 582953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Penetration of cloxacillin into human bone tissue after oral administration (author's transl)].
    Sirot J; Lopitaux R; Dumont C; Delisle JJ; Rampon S; Cluzel R
    Pathol Biol (Paris); 1982 Jun; 30(6):332-5. PubMed ID: 7050842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bone levels after intramuscular administration of cephradine ('Velosef') or flucloxacillin/ampicillin in hip replacement.
    Brooks S; Dent AR
    Pharmatherapeutica; 1984; 3(10):642-9. PubMed ID: 6463064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone diffusion of cefotiam in men].
    Farinotti R; Vie P; Montes C; Cavagna R; Rosembaum M; Duparc J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):638-42. PubMed ID: 2797889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the penetration of cefuroxime and cephamandole into bone, fat and haematoma fluid in patients undergoing total hip replacement.
    Lovering AM; Perez J; Bowker KE; Reeves DS; MacGowan AP; Bannister G
    J Antimicrob Chemother; 1997 Jul; 40(1):99-104. PubMed ID: 9249210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffusion of cefamandole into the prostatic tissue (author's transl)].
    Adam D; Hofstetter AG; Eisenberger F
    Med Klin; 1979 Feb; 74(7):235-8. PubMed ID: 84331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cefamandole for perioperative prophylaxis in total hip alloplasty].
    Jackowiak M; Buczkowski T
    Chir Narzadow Ruchu Ortop Pol; 1997; 62(1):55-8. PubMed ID: 9198547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of cefoperazone and cefamandole.
    Srinivasan S; Francke EL; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of cephalosporins into bone.
    Cunha BA; Gossling HR; Pasternak HS; Nightingale CH; Quintiliani R
    Infection; 1984; 12(2):80-4. PubMed ID: 6735481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole in the treatment of serious bone and joint diseases.
    Levine LR
    Scand J Infect Dis Suppl; 1980; suppl 25():89-93. PubMed ID: 7010542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.